Factors associated with improvement or decline in cognitive function after an ischemic stroke in Korea: the Korean stroke cohort for functioning and rehabilitation (KOSCO) study. Issue 1 (December 2017)

• Record Type: Journal Article
• Authors: Yoon, Jin; Kim, Deog; Sohn, Min; Lee, Jongmin; Lee, Sam-Gyu; Lee, Yang-Soo; Han, Eun; Joo, Min; Oh, Gyung-Jae; Han, Junhee; Park, Minsu; Park, Kyung; Noh, Kyung-Ha; Chang, Won; Shin, Yong-Il; Kim, Yun-Hee
• Is Part Of: BMC neurology. Volume 17:Issue 1(2017)
• Page Start: 1
• Page End: 12
• Publication Date: 2017-12
• Subjects: Ischemic stroke -- Cognition -- Inverter -- Reverter -- Risk factors; Neurology -- Periodicals; 616.8005
• DOI: 10.1186/s12883-016-0780-3
• Languages: English
• ISSNs: 1471-2377

Abstract

Abstract Background We conducted a prospective cohort study to investigate prevalence of poststroke cognitive impairment at 3 and 12 months after stroke onset and identify clinical and demographic factors associated with improvement or decline in cognitive function between 3 months and 12 months. Methods We analyzed the cognitive assessments of total patients and patients older than 65 years separately. All patients with an ischemic stroke were divided into normal cognitive group (NCG) and impaired cognition group (ICG) by using a cutoff score on the Korean Mini-Mental State Examination (K-MMSE). Patients were additionally classified into 3 subgroups according to the changes in their K-MMSE scores between 3 and 12 months: Stable group with K-MMSE scores changes ranging from −2 to +2 points (−2 ≤ △MMSE ≤ +2); converter group with increase more than 3 points (3 ≤ △MMSE); and reverter group with decrease more than 3 points (−3 ≤ △MMSE). We also analyzed factors affecting cognitive change from 3 months to 12 months among the 3 groups including baseline medical record, stroke and treatment characteristics, and various functional assessments after 3 months. Results This study included 2, 625 patients with the first time ischemic stroke. Among these patients, 1, 735 (66.1%) were classified as NCG, while 890 patients (33.9%) were belonged to the ICG at 3 month. Within the NCG, 1, 460 patients (82.4%) were stable group, 93 patients (5.4%) were converter group, and 212 patients (12.2%) were reverter group at 12 months onset. Within the ICG group, 472 patients (53.0%) were stable group, 321 patients (36.1%) were converter group, and 97 patients (10.9%) were reverter group. When different factors were investigated, the three subgroups in NCG and ICG showed significant different factors affecting cognitive function from 3 to 12 month. Conclusions The prevalence of cognitive impairment showed difference between 3, 12 months. To analyze the cognitive change from 3 month to 12 month, the proportion stable group was dominant in NCG and converter group was higher in ICG. By investigating the influencing factors from each group, we were able to identify the predictors including the age factor.